Page last updated: 2024-11-06

n-benzylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

n-Benzylglycine, also known as phenylglycine, is a non-proteinogenic amino acid. It is a key precursor in the synthesis of the artificial sweetener aspartame. It is also used in the production of other pharmaceuticals and agricultural chemicals. Research into n-benzylglycine focuses on its role in aspartame production, its potential applications in other synthetic processes, and its environmental impact.'

Cross-References

ID SourceID
PubMed CID86965
CHEMBL ID453029
SCHEMBL ID156664
MeSH IDM0384039

Synonyms (52)

Synonym
EU-0096385
AC-2979
n-benzyl glycine
AKOS002392487
nsc166840
17136-36-6
nsc-166840
n-(phenylmethyl)glycine
n-benzylglycine
2-(benzylazaniumyl)acetate
CHEMBL453029
2-(benzylamino)acetic acid
A18302
unii-dpa13kz0sr
einecs 241-194-9
nsc 166840
dpa13kz0sr ,
A825260
2-[(phenylmethyl)amino]acetic acid
2-[(phenylmethyl)amino]ethanoic acid
2-(benzylamino)-acetic acid
AM803326
FT-0637505
AB04524
(benzylamino)acetic acid
AB01319804-02
n -benzylglycine
benzylglycine
n-benzylglycin
benzyl glycine
SCHEMBL156664
mfcd00190772
SY003481
TS-00128
W-107874
STR07545
(benzylamino)acetic acid #
glycine, n-(phenylmethyl)-
DTXSID10169071
F0917-2364
SR-01000579522-1
sr-01000579522
CS-W016075
(n-benzylamino)acetic acid
AB6138
Q27449843
NCGC00324683-01
SB76749
EN300-56244
2-(benzylamino)aceticacid
HY-W015359
PD196966
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID388280Inhibition of Blattella germanica peptidylamidoglycolate lyase assessed as ascorbate-independent dealkylation of alpha-hydroxy-hipurate2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID388275Inhibition of rat recombinant peptidylglycine alpha-amidating monooxygenase assessed as inhibition of N-dansyl-Tyr-Val-Gly amidation2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.53 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index19.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]